Loading...
Customizing the genome as therapy for the β-hemoglobinopathies
Despite nearly complete understanding of the genetics of the β-hemoglobinopathies for several decades, definitive treatment options have lagged behind. Recent developments in technologies for facile manipulation of the genome (zinc finger nucleases, transcription activator-like effector nucleases, o...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4882803/ https://ncbi.nlm.nih.gov/pubmed/27053533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-01-678128 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|